Everything we covered on WTR over the past seven days, and all you need to know from the world of trademarks to set yourself up for the start of another busy week.

Like every pharmaceutical company, GSK has seen patents expire on a string of blockbuster drugs, allowing generic rivals to ...

Congress in Spain were a major feature of research news last week, including those from Pfizer on it ponsegromab in cancer ...

GSK Plc and Bayer AG leave the country or appoint third parties to distribute their products due to foreign exchange shortages. Tinubu, in office since May last year, said his government wanted to ...

The graft versus host disease market is experiencing significant growth, driven by the ongoing adoption of branded therapies such as JAKAFI, IMBRUVICA, ORENCIA, and REZUROCK compared to off-label ...